MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board
Dr. Robert C. Malenka is the Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford University NEW YORK, March 29, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. (“MindMed” or the “Company”) (NEO: MMED), (OTCQB: MMEDF), (DE: MMQ), a leading psychedelic medicine biotech company, has announced the addition […]
BetterLife Added to Horizons Psychedelic Stock Index ETF
VANCOUVER, March 29, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU ) is pleased to announce that it has been added to the Horizons Psychedelic Stock Index ETF ( PSYK : NEO), the world’s first ETF offering direct exposure to North American publicly listed securities that have significant business activities in, or significant exposure […]